Research on drug abuse and addiction requires multi-disciplinary approaches. The Biochemical Pharmacology Core provides services for researchers who do not perform biochemical pharmacology assays. The techniques provided in this Core allow interrogation of receptors associated with drugs of abuse and their signaling. Most researchers who used the Core are either behavioral scientists or chemists. The services provided by the Core are valuable to these investigators, expanded their research and have resulted in many publications. The Core also has provided preliminary data for grant applications and several NIH grants were awarded. The receptors of drugs of abuse that the Core has investigated to date include opioid receptors (MOPR, DOPR, KOPR, NOPR), cannabinoid (CB1 and CB2) receptors, nicotinic cholinergic receptors (nAChRs) and dopamine and sigma receptors. In the requested funding period, the Core will perform the following services: (1) Radioligand binding to the aforementioned receptors related to drug abuse and others when necessary; (2) Assessment of G protein-coupled receptor (GPCR) activation, including cAMP level, [35S]GTP?S binding, p44/42 MAP kinases phosphorylation, ?-arrestin recruitment; (3) Determination of agonist bias for GPCRs using [35S]GTP?S binding or cAMP and ?-arrestin recruitment and CRISPR cell lines; (4) Autoradiography of radioligand binding to opioid and dopamine receptors and (5) Autoradiography of opioid agonist- promoted [35S]GTP?S binding in brain sections; (6) Immunoblotting of MOPR, KOPR and phosphorylated KOPR in cultured cells and in rodent brains; (7) Internalization of MOPR, DOPR and KOPR and CB1 in cultured cells and KOPR in mouse brains; (8) Providing purified antibodies against MOPR, KOPR and phospho-KOPR to researchers; (9) Training of personnel of other laboratories. For the requested grant period, the Core will perform at least 15 collaborative projects with NIH-funded investigators across the country. The innovation lies in the proposed studies, which will address a wide variety of questions related to drug abuse, including elucidation of impact of adolescent and adult chronic exposure to morphine, cocaine or nicotine on MOPR, dopamine and/or nAChR expression and/or signaling in adults and offspring, respectively; search for KOPR agonists that do not cause KOPR phosphorylation (likely G protein-biased); effects of AMP-activated protein kinase (AMPK) deletion on expression of MOPR and nAChR; screening for allosteric modulators of CB1 receptors and determination of how they alter ligand binding; and investigation of agonist biases for CB1 and CB2 receptors by using CRISPR cell lines with either individual G proteins or arrestins deleted. The studies are novel and the Core will augment these research projects beyond the original scope. Thus, the Core will make significant contribution to the area of substance abuse research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
2P30DA013429-21
Application #
9845445
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
21
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Cotto, Bianca; Li, Hongbo; Tuma, Ronald F et al. (2018) Cocaine-mediated activation of microglia and microglial MeCP2 and BDNF production. Neurobiol Dis 117:28-41
Ward, Sara Jane; Castelli, Francesca; Reichenbach, Zachary W et al. (2018) Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sci 195:1-5
Liu, Jeffrey J; Sharma, Kirti; Zangrandi, Luca et al. (2018) In vivo brain GPCR signaling elucidated by phosphoproteomics. Science 360:
Oliver, Chicora F; Simmons, Steven J; Nayak, Sunil U et al. (2018) Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. Drug Alcohol Depend 186:75-79
Zewde, Ashenafi Mebratu; Yu, Frances; Nayak, Sunil et al. (2018) PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects. J Neurosci Methods 293:284-288
Rom, Slava; Zuluaga-Ramirez, Viviana; Reichenbach, Nancy L et al. (2018) Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation. J Neuroinflammation 15:25
Ramirez, Servio H; Andrews, Allison M; Paul, Debayon et al. (2018) Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers. Fluids Barriers CNS 15:19
Brailoiu, Eugen; Barlow, Christine L; Ramirez, Servio H et al. (2018) Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells. Neuroscience 377:105-113
Barbe, Mary F; Massicotte, Vicky S; Assari, Soroush et al. (2018) Prolonged high force high repetition pulling induces osteocyte apoptosis and trabecular bone loss in distal radius, while low force high repetition pulling induces bone anabolism. Bone 110:267-283
Gentile, Taylor A; Simmons, Steven J; Barker, David J et al. (2018) Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addict Biol 23:247-255

Showing the most recent 10 out of 343 publications